Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Trafficking of Connexin36 (Cx36) in the early secretory pathway
Author Affiliations & Notes
  • Stephan Tetenborg
    College of Optometry, University of Houston System, Houston, Texas, United States
  • Eyad Shihabeddin
    College of Optometry, University of Houston System, Houston, Texas, United States
    Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, United States
  • Abirami Santhanam
    College of Optometry, University of Houston System, Houston, Texas, United States
  • John O'Brien
    College of Optometry, University of Houston System, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Stephan Tetenborg None; Eyad Shihabeddin None; Abirami Santhanam None; John O'Brien None
  • Footnotes
    Support  Deutsche Forschungsgemeinschaft (DFG) (TE 1459/1-1, Walter Benjamin stipend) to S.T, NIH Grant R01EY012857 to J.O, UT core grant P30EY028102
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4493. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephan Tetenborg, Eyad Shihabeddin, Abirami Santhanam, John O'Brien; Trafficking of Connexin36 (Cx36) in the early secretory pathway. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4493.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Connexin36 (Cx36) containing gap junctions are critical components for retinal signal processing, providing unique functions such as signal averaging or cell synchronization. While the physiological features of gap junctions in electrically coupled networks have been intensively studied, little is known about the molecular mechanisms that control the transport of connexins in retinal neurons. Previous studies have shown that expression of a Cx36-EGFP construct carrying a dysfunctional C-terminus interferes with the formation of electrical synapses in the retina. These observations indicate that a fully functional C-terminus in Cx36 is necessary to deliver the connexin to the synapse. The underlying molecular pathway responsible for the transport deficit is currently unknown and subject of the present study.

Methods : Site directed mutagenesis and HEK293T cells serving as an expression system were used to characterize transport deficits of individual Cx36 mutants. A proximity labeling strategy in combination with mass spectrometry was used to identify novel proteins that associate with the carboxy terminus of Cx36. Functional interactions with candidate proteins were verified by siRNA screens and pull-down assays. For each experimental condition, confocal scans were acquired to analyze the distribution of Cx36 in transfected HEK293 cells.

Results : Expression of Cx36 mutants that lacked tyrosine and valine at the extreme C-terminus led to an intracellular accumulation in transfected HEK293T cells. Double labeling experiments demonstrated that these aggregates originated from the ER. To search for proteins that mediate the transport of Cx36 at ER exit sites we performed a BioID assay using a Cx36-TurboID construct. This screen identified several COPII components, including cargo receptors and the Golgi stacking protein GRASP55. siRNA mediated knockdown of all four COPII cargo receptors, revealed that only the combined depletion of Sec24A and B blocked the ER export of Cx36.

Conclusions : In the present study we have dissected the molecular mechanism that guides the transport of Cx36 in the early secretory pathway. Our data indicate that a C-terminal motif, comprising the amino acids tyrosine and valine, is required for Cx36 to bind specific cargo receptors of the COPII complex enabling the recruitment of newly synthesized connexons into ER export vesicles.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×